If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks1Spatial Holdings Regulatory News (SPA)

  • This share is currently suspended. It was suspended at a price of 72.80
  • There is currently no data for SPA

Rule 8.1- Xploite plc

13 Apr 2010 07:00

RNS Number : 0499K
Avisen PLC
13 April 2010
 



FORM 8.1

DEALINGS BY OFFERORS, OFFEREE COMPANIES OR THEIR ASSOCIATES

FOR THEMSELVES OR FOR DISCRETIONARY CLIENTS

(Rules 8.1(a) and (b)(i) of the Takeover Code)

 

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

Avisen plc

Company dealt in

Xploite plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

Ordinary Shares of 10 pence each

Date of dealing

12 April 2010

 

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

 

Long

Short

 

 

Number (%)

Number (%)

(1) Relevant securities

 

1

N/A

(2) Derivatives (other than options)

 

N/A

N/A

(3) Options and agreements to purchase/sell

 

N/A

N/A

Total

 

1

N/A

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 

Class of relevant security:

 

Long

Short

 

 

Number (%)

Number (%)

(1) Relevant securities

 

N/A

N/A

(2) Derivatives (other than options)

 

N/A

N/A

(3) Options and agreements to purchase/sell

 

N/A

N/A

Total

 

N/A

N/A

 

(c) Rights to subscribe (Note 3)

 

Class of relevant security:

 

Details

N/A

N/A

 

 

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale

 

Number of securities

Price per unit (Note 5)

 

Purchase

1

£0.39

 

 

(b) Derivatives transactions (other than options)

 

Product name,

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

N/A

 

N/A

N/A

N/A

 

 

 

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price

Type, e.g. American, European etc.

Expiry

date

Option money

paid/received per unit (Note 5)

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)

N/A

N/A

N/A

 

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8)

 

Details

Price per unit (if applicable) (Note 5)

N/A

 

N/A

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

N/A

 

 

 

Is a Supplemental Form 8 attached? (Note 9) NO

 

 

Date of disclosure

13 April 2010

Contact name

Marcus Yeoman

Telephone number

087088 02978

Name of offeree/offeror with which associated

Avisen plc

Specify category and nature of associate status (Note 10)

N/A

 

 

Notes

 

The Notes on Form 8.1 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DCCUUASRROASAAR
Date   Source Headline
7th Jan 20081:37 pmRNSResult of EGM
27th Dec 20078:39 amRNSAssignment of Lease
21st Dec 20073:49 pmRNSPosting of Circular
20th Dec 20074:23 pmRNSConditional disposal
29th Nov 20078:00 amRNSFirst Day of Trading
29th Nov 20077:00 amRNSInterims & Proposed Disposal
12th Sep 20077:01 amRNSTrading Statement
13th Aug 20077:00 amRNSAIM Rule 26
30th Jul 20072:03 pmRNSAGM and Directorate Change
26th Jul 20077:00 amRNSProduct Launch
20th Jul 20077:00 amPRNRe Agreement
26th Jun 20071:17 pmRNSStmnt re Share Price Movement
11th Jun 20077:00 amPRNFinal Results
3rd Apr 200711:17 amRNSHolding(s) in Company
19th Mar 20077:01 amRNSTrading Statement
1st Mar 20079:42 amRNSTotal Voting Rights
21st Feb 20077:00 amRNSChange of Registered Address
20th Feb 20076:27 pmRNSDirector/PDMR Shareholding
2nd Feb 20077:00 amRNSRe Agreement
30th Jan 20072:53 pmRNSDirector/PDMR Shareholding
30th Jan 200712:00 pmRNSTrading Statement
21st Dec 20062:51 pmRNSTotal Voting Rights
20th Dec 20063:54 pmRNSDirector/PDMR Shareholding
20th Dec 20063:45 pmRNSDirector/PDMR Shareholding
19th Dec 20067:01 amRNSDirector/PDMR Shareholding
18th Dec 20065:23 pmRNSDirector/PDMR Shareholding
18th Dec 20065:18 pmRNSDirector/PDMR Shareholding
15th Dec 20061:12 pmRNSResult of EGM
30th Nov 20066:15 pmRNSNotification of Interest
29th Nov 20068:40 amRNSIssue of Equity
27th Nov 200612:43 pmRNSStmnt re Share Price Movement
22nd Nov 20065:45 pmRNSIssue of Equity
22nd Nov 20065:39 pmRNSCirc re. Acquistion
21st Nov 20067:01 amRNSInterim Results
11th Sep 20061:50 pmRNSFurther re Product Agreements
4th Sep 20061:18 pmRNSDirectorate Change
14th Jul 20061:47 pmRNSDirector's Dealings
13th Jul 20065:01 pmRNSNotifiable Interest
5th Jul 200611:52 amRNSResult of AGM
4th Jul 20067:00 amRNSDirectorate Change
12th Jun 20067:02 amRNSFurther re Product Launch
8th Jun 20067:02 amRNSRe Agreement
31st May 20067:03 amRNSFinal Results
31st May 20067:03 amRNSDirectorate Change
31st May 20067:03 amRNSChange of Adviser
31st Mar 20067:03 amRNSProduct Launch
30th Mar 20068:16 amRNSTrading Statement
8th Mar 20067:02 amRNSProduct Launch
2nd Mar 200610:07 amRNSDirector/PDMR Shareholding
7th Feb 20067:05 amRNSProduct Launch

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.